OBJECTIVE: To evaluate whether higher circulating levels of complement proteins C3 and C4 are associated with menopausal status and with hemostatic/thrombus formation markers (circulating factor VII (factor VIIc), fibrinogen, plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator antigen (tPA-ag)) in a sample of midlife women. METHODS AND RESULTS: A total of 100 women (50 late peri-/postmenopausal and 50 pre-/early peri- menopausal women) from the Study of Women's Health Across the Nation (SWAN) Pittsburgh site were included in the present analysis. Factor VIIc and PAI-1 were log transformed. Linear regression was used for analysis. The mean age of the study participants was 50.5 ± 2.6 years with 73% were Caucasian and 27% were African American. C3 but not C4 was significantly higher in postmenopausal women compared to premenopausal women (P value = 0.03), adjusting for age, race and BMI. In final model (adjusting for age, race, BMI and menopausal status), C3 was associated with higher levels of log PAI-1 (P value = 0.0009) and tPA-ag (P value = 0.0003), while C4 was associated with higher levels of log factor VIIc (P value = 0.04) and fibrinogen (P value = 0.005). CONCLUSIONS: These data suggest that C3 and C4 may be related to blood clots via their associations with hemostatic markers and that C3 is related to menopausal status. Complement proteins C3 and C4 could be possible pathways by which postmenopausal women are at higher risk of atherosclerosis and cardiovascular related events. It is important to replicate these findings in a larger sample size.
OBJECTIVE: To evaluate whether higher circulating levels of complement proteins C3 and C4 are associated with menopausal status and with hemostatic/thrombus formation markers (circulating factor VII (factor VIIc), fibrinogen, plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator antigen (tPA-ag)) in a sample of midlife women. METHODS AND RESULTS: A total of 100 women (50 late peri-/postmenopausal and 50 pre-/early peri- menopausal women) from the Study of Women's Health Across the Nation (SWAN) Pittsburgh site were included in the present analysis. Factor VIIc and PAI-1 were log transformed. Linear regression was used for analysis. The mean age of the study participants was 50.5 ± 2.6 years with 73% were Caucasian and 27% were African American. C3 but not C4 was significantly higher in postmenopausal women compared to premenopausal women (P value = 0.03), adjusting for age, race and BMI. In final model (adjusting for age, race, BMI and menopausal status), C3 was associated with higher levels of log PAI-1 (P value = 0.0009) and tPA-ag (P value = 0.0003), while C4 was associated with higher levels of log factor VIIc (P value = 0.04) and fibrinogen (P value = 0.005). CONCLUSIONS: These data suggest that C3 and C4 may be related to blood clots via their associations with hemostatic markers and that C3 is related to menopausal status. Complement proteins C3 and C4 could be possible pathways by which postmenopausal women are at higher risk of atherosclerosis and cardiovascular related events. It is important to replicate these findings in a larger sample size.
Authors: Miklós Sárvári; Imre Kalló; Erik Hrabovszky; Norbert Solymosi; Kinga Tóth; István Likó; Béla Molnár; Károly Tihanyi; Zsolt Liposits Journal: Endocrinology Date: 2010-06-09 Impact factor: 4.736
Authors: Donald Lloyd-Jones; Robert J Adams; Todd M Brown; Mercedes Carnethon; Shifan Dai; Giovanni De Simone; T Bruce Ferguson; Earl Ford; Karen Furie; Cathleen Gillespie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; P Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary M McDermott; James Meigs; Dariush Mozaffarian; Michael Mussolino; Graham Nichol; Véronique L Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Véronique L Roger; Randall Stafford; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan D Wong; Judith Wylie-Rosett Journal: Circulation Date: 2009-12-17 Impact factor: 29.690
Authors: János P Kósa; Bernadett Balla; János Kiss; János Podani; István Takács; Aron Lazáry; Zsolt Nagy; Krisztián Bácsi; Attila Karsai; Gábor Speer; Péter Lakatos Journal: J Clin Immunol Date: 2009-08-07 Impact factor: 8.317
Authors: Ping G Tepper; John F Randolph; Daniel S McConnell; Sybil L Crawford; Samar R El Khoudary; Hadine Joffe; Ellen B Gold; Huiyong Zheng; Joyce T Bromberger; Kim Sutton-Tyrrell Journal: J Clin Endocrinol Metab Date: 2012-06-01 Impact factor: 5.958
Authors: Joanna-Marie Howes; Victoria R Richardson; Kerrie A Smith; Verena Schroeder; Riyaz Somani; Anna Shore; Katharina Hess; Ramzi Ajjan; Richard J Pease; Jeffrey N Keen; Kristina F Standeven; Angela M Carter Journal: Diab Vasc Dis Res Date: 2012-01-17 Impact factor: 3.291
Authors: Samar R El Khoudary; Lin Wang; Maria M Brooks; Rebecca C Thurston; Carol A Derby; Karen A Matthews Journal: J Clin Lipidol Date: 2016-04-26 Impact factor: 4.766
Authors: Norman C Wang; Karen A Matthews; Emma J M Barinas-Mitchell; Chung-Chou H Chang; Samar R El Khoudary Journal: Menopause Date: 2016-06 Impact factor: 2.953
Authors: Nayana Nagaraj; Karen A Matthews; Kelly J Shields; Emma Barinas-Mitchell; Matthew J Budoff; Samar R El Khoudary Journal: Atherosclerosis Date: 2015-10-24 Impact factor: 5.162
Authors: Norman C Wang; Karen A Matthews; Emma J M Barinas-Mitchell; Chung-Chou H Chang; Samar R El Khoudary Journal: Am J Cardiol Date: 2016-05-14 Impact factor: 2.778
Authors: Jasmin Maria Bülow; Nikolai Renz; Melanie Haffner-Luntzer; Verena Fischer; Astrid Schoppa; Jan Tuckermann; Jörg Köhl; Markus Huber-Lang; Anita Ignatius Journal: Front Endocrinol (Lausanne) Date: 2022-09-30 Impact factor: 6.055